Brief: Grand Pharmaceutical Group Posts FY Revenue HK$9,562.29 Mln VS Hk$8,597.98 Mln
22/03/2023 15:29
March 22 (Reuters) - Grand Pharmaceutical Group Ltd
0512.HK :
* FY REVENUE HK$9,562.29 MILLION VERSUS HK$8,597.98 MILLION
* FY PROFIT ATTRIBUTABLE HK$2,137.33 MILLION, INCREASE OF
11.5%
Source text for Eikon: ID:nHKS4pBnsf
Further company coverage: 0512.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Grand Pharmaceutical
See all newsBrief: Grand Pharmaceutical Group Declares No Interim Dividend Has Been Paid
Grand Pharmaceutical H1 revenue rises on nuclear medicine demand
Grand Pharma rises most in over a year as drug gets US FDA fast track designation
GPN01530-2 Granted Fast Track Designation By FDA
Brief: Grand Pharmaceutical Group Enters Huadong Medicine Supply Agreement